REDUCE LAP-HF: Transcatheter Interarterial Shunt Device Shows Benefit for Patients With HFpEF at 1 Year
A transcatheter interatrial shunt device improved quality of life, improved exercise capacity and showed acceptable major adverse cardiovascular and cerebrovascular events rates at one year in patients with heart failure with preserved ejection fraction, according to a presentation at the American Heart Association Scientific Sessions. Data from the REDUCE LAP-HF study also showed patency of the shunt device (IASD System, Corvia Medical) as well as clinical and hemodynamic benefit at six months and one year.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063